Mechanistically, IMPDH inhibition reduces the expression, complex formation, and chromatin binding of the LEDGF-menin-MLL complex and renders MLLr AML cells highly sensitive to menin inhibitors. The gene discussed is KMT2A; the disease is acute myeloid leukemia.